Skip to main content
Navigate back to homepage
Open search bar.
Open main navigation menu

Main navigation

  • Study
    UCL Portico statue
    Study at UCL

    Being a student at UCL is about so much more than just acquiring knowledge. Studying here gives you the opportunity to realise your potential as an individual, and the skills and tools to thrive.

    • Undergraduate courses
    • Graduate courses
    • Short courses
    • Study abroad
    • Centre for Languages & International Education
  • Research
    Tree-of-Life-MehmetDavrandi-UCL-EastmanDentalInstitute-042_2017-18-800x500-withborder (1)
    Research at UCL

    Find out more about what makes UCL research world-leading, how to access UCL expertise, and teams in the Office of the Vice-Provost (Research, Innovation and Global Engagement).

    • Engage with us
    • Explore our Research
    • Initiatives and networks
    • Research news
  • Engage
    UCL Print room
    Engage with UCL

    Discover the many ways you can connect with UCL, and how we work with industry, government and not-for-profit organisations to tackle tough challenges.

    • Alumni
    • Business partnerships and collaboration
    • Global engagement
    • News and Media relations
    • Public Policy
    • Schools and priority groups
    • Visit us
  • About
    UCL welcome quad
    About UCL

    Founded in 1826 in the heart of London, UCL is London's leading multidisciplinary university, with more than 16,000 staff and 50,000 students from 150 different countries.

    • Who we are
    • Faculties
    • Governance
    • President and Provost
    • Strategy
  • Active parent page: Brain Sciences
    • Study
    • Research
    • About the Faculty
    • Institutes and Divisions
    • Active parent page: News and Events
    • Contact

UCL Institute of Neurology researchers awarded MRC fellowships

Breadcrumb trail

  • Brain Sciences
  • News and Events

Faculty menu

  • Current page: Faculty news
  • Events

Fellowships were recently awarded to researchers supported by the BRC, the National Institute for Health Research and the NIHR Queen's Square Dementia Biomedical Research Unit.   

Ten awards were granted nationally from the Medical Research Council, with four going to Dr Pietro Fratta, Dr Jonathan Rohrer, Dr Ed Wild and Dr Gavin Winston, all from the UCL Institute of Neurology.  

Dr Fratta’s fellowship will focus on amyotrophic lateral sclerosis (ALS), a rapidly progressive neurological disease that attacks the nerve cells. Dr Fratta will explore RNA metabolism in ALS, testing whether RNA molecules, which allow the information contained in the DNA to be carried out in cells, are crucial for motor neurons to survive and what role this plays in motor neuron disease.

In the past five years a series of genetic discoveries have made it apparent that a number of crucial genes are involved in various steps of RNA metabolism.

I will start with understanding what types of RNA are in the axons of motor neurons. Once I’ve characterised this, I will attempt to understand how the RNA in ALS axons is different to healthy axons. I want to test whether alterations in the transport and distribution of RNA in axons is important in ALS – we already know that RNA transport alterations are present in numerous neurodegenerative disorders, but the role of RNA still needs to be addressed. Dr Fratta, Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology

Dr Rohrer will use his fellowship to identify new biomarkers in frontotemporal dementia (FTD), the second most common form of young-onset dementia after Alzheimer’s disease. Dr Rohrer will look at MRI imaging, PET imaging, cerebrospinal fluid and serum markers. Dr Rohrer will measure when they first become abnormal and how they change over time to know when the best time is to give disease-modifying therapy
Dr Rohrer and his team wish to see how early change can be seen, particularly in FTD groups who have a genetic mutation from birth but only develop symptoms in their fifties or sixties.

Unlike Alzheimer’s disease, where there are pathological protein aggregations and CSF markers, there aren’t really any good biomarkers of the underlying pathology in FTD. We want to know when the best time is to give disease-modifying therapy and how we should monitor whether therapies are working. If we see changes in our youngest subjects in their twenties who may be 30 or 40 years away from developing symptoms possibly the best time to treat people is at a very young age. Dr Rohrer, Department of Neurodegenerative Diseases, UCL Institute of Neurology

Dr Wild aims to develop further our understanding of the neuropathobiology of Huntingtons Disease by studying patients’ cerebrospinal fluid and how the brain responds to things that go wrong.

I am studying how a gene becomes a disease: the gene is expressed in the protein and the protein messes up molecular things inside the cell causing cells to malfunction and die. Collecting CSF gives us a unique chance to study chemical changes in the nervous system of patients by measuring mutant Huntingtin levels. Dr Ed Wild, Department of Neurodegenerative Diseases, UCL Institute of Neurology

Dr Winston’s research focuses on pre-surgical evaluation in refractory focal epilepsy, a type of epilepsy that means medicines don't work well, or at all, to control seizures. At the moment, a range of different techniques are used to study refractory focal epilepsy such as imaging (MRI, PET and Single-Photon Emission Computed Tomography SPECT, EEG, and neuropsychology. Currently, these techniques are expensive and time consuming. In addition, they do not always find where seizures are coming from. Dr Winston will use a combination of these techniques to identify where seizures are coming from.

We can more rapidly, and cost effectively, use imaging to identify abnormalities in patients in who we can’t identify abnormalities with current techniques. This will hopefully allow a larger number of patients to have surgery.Dr Winston, Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology
I would like to congratulate Dr Pietro Fratta, Dr Jonathan Rohrer, Dr Ed Wild and Dr Gavin Winston on winning these highly competitive national MRC awards. It is quite remarkable that four out of 10 national awards have come to researchers at the Institute of Neurology. These very promising researchers are all pursuing important translational research questions that are likely to have impact for patients. These projects align strongly with the mission of the Institute of Neurology to translate world class science into new diagnostics and treatments for patients. Professor Michael Hanna, Director of the UCL Institute of Neurology

Further information:

  • Dr Fratta's academic profile on IRIS
  • Dr Rohrer's academic profile on IRIS
  • Dr Wild's academic profile on IRIS
  • Dr Winston's academic profile on IRIS
  • MRC Clinical Scientist Fellowships

UCL footer

Visit

  • Bloomsbury Theatre and Studio
  • Library, Museums and Collections
  • UCL Maps
  • UCL Shop
  • Contact UCL

Students

  • Accommodation
  • Current Students
  • Moodle
  • Students' Union

Staff

  • Inside UCL
  • Staff Intranet
  • Work at UCL
  • Human Resources

UCL social media menu

  • Link to Soundcloud
  • Link to Flickr
  • Link to TikTok
  • Link to Youtube
  • Link to Instagram
  • Link to Facebook
  • Link to Twitter

University College London, Gower Street, London, WC1E 6BT

Tel: +44 (0) 20 7679 2000

© 2025 UCL

Essential

  • Disclaimer
  • Freedom of Information
  • Accessibility
  • Cookies
  • Privacy
  • Slavery statement
  • Log in